Our Institutional Review Board is an independent committee established to continuously review clinical research plans, modifications and perform checks on clinical methodology.
It is also responsible for integral assessment of patient information and informed written consent from subjects, to protect the rights, safety and welfare of all participants and medical staff.

With bioethics firmly based on the principles of The Declaration of Helsinki, we are also governed through biosafety guidelines set out by the Department of Health and Human Services, Korean Good Clinical Practice (GCP) standards from the Korea Food and Drug Administration and related regulations from the ICH-GCP to ensure ethical and scientific validity for all research processes.